Sheera R. Rosenbaum
-
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 2
- HER2/EGFR in Cancer Research 2
-
- Immunotherapy and Immune Responses 2
- Immune Cell Function and Interaction 2
-
- Melanoma and MAPK Pathways 5
- Renal and related cancers 2
- Inflammasome and immune disorders 2
- Co-authors
- Andrew E. AplinNicole A. WilskiTimothy J. PurwinMichael A. DaviesAdam C. BergerClaudia CapparelliInna ChervonevaHa Linh Vu
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- United StatesIsrael
In The Last Decade
Sheera R. Rosenbaum
13 papers receiving 409 citations
Peers
Comparison fields: 5 of 57
- Oncology 185
- Immunology 139
- Cancer Research 67
- Molecular Biology 238
- Pulmonary and Respiratory Medicine 89
Countries citing papers authored by Sheera R. Rosenbaum
This map shows the geographic impact of Sheera R. Rosenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheera R. Rosenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheera R. Rosenbaum more than expected).
Fields of papers citing papers by Sheera R. Rosenbaum
This network shows the impact of papers produced by Sheera R. Rosenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheera R. Rosenbaum. The network helps show where Sheera R. Rosenbaum may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sheera R. Rosenbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 8 | |
| 5 | 2021 | 20 | |
| 6 | 2021 | 131 | |
| 7 | 2020 | 62 | |
| 8 | 2019 | 36 | |
| 9 | 2019 | 11 | |
| 10 | 2015 | 47 | |
| 11 | 2015 | 12 | |
| 12 | 2015 | 18 | |
| 13 | 2015 | 55 |
About Sheera R. Rosenbaum
Sheera R. Rosenbaum is a scholar working on Oncology, Immunology and Molecular Biology, having authored 13 papers that have together received 410 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Melanoma and MAPK Pathways (5 papers), CAR-T cell therapy research (2 papers), Immunotherapy and Immune Responses (2 papers), Renal and related cancers (2 papers), HER2/EGFR in Cancer Research (2 papers), Immune Cell Function and Interaction (2 papers) and Inflammasome and immune disorders (2 papers). The work is most often cited by research in Oncology (185 citations), Immunology (139 citations) and Cancer Research (67 citations). Sheera R. Rosenbaum has collaborated with scholars based in United States and Israel. Frequent co-authors include Andrew E. Aplin, Nicole A. Wilski, Timothy J. Purwin, Michael A. Davies, Adam C. Berger, Claudia Capparelli, Inna Chervoneva, Ha Linh Vu, Dan A. Erkes and Manoela Tiago. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.